Stocks›Healthcare›NTLA

NTLA

Intellia Therapeutics, Inc.

NasdaqResearch view

Intellia Therapeutics, Inc. operates in the In Vitro & In Vivo Diagnostic Substances industry.

$12.37−2.98%

Oct 6 close · 1D EOD · Databento

HealthcareIn Vitro & In Vivo Diagnostic SubstancesSmall-capSEC EDGAR FY 2025-12-31

What happened

Daily closes · dots are Wire stories

What’s next

Expected around early November, going by its own filing history. The company has not announced a date yet. Its matching report came Nov 6, 2025 and Nov 7, 2024, during the session.

Last report

Aug 6, 2026+2.46%

during the session

Last 4, next close

median 4.44% either way

up 3 of 4

Every report since 2023 →Earnings calendar →

DateEventSourceNext close

Aug 6Earnings release, during the session · 8-KSEC EDGARSEC EDGAR ↗+2.46%

Next close = the first close after the event against the close before it. Prior-session closes only; not a call, not advice.

What happened · big days

21 big days in a year, and what we hold on each

A big day is a close more than 8.67% from the one before, three times NTLA’s median day (2.89%). On 0 of the 21, its peer group moved the same way at least half as far. We show what we hold. We never name a cause.

every other trading daya big day, numbered in the list below±8.67%Hover a bar for its day. Click a big day to open it.

Shaded: since our stories began, Jun 10. Tap a bar for its day.

#DayNTLAWhat we hold that dayGroup (median of 4) · each

1 Oct 8, 2025+19.72%
Before our storiesgroup +3.6%, did not move with it
1Oct 8, 2025+19.72%
Before our stories
+3.6% did not move with itNEOG +4.1 · CLDX +3.9 · LNTH +3.3 · IDXX +0.4
2 Oct 20, 2025+13.05%
Before our storiesgroup +1.5%, did not move with it
2Oct 20, 2025+13.05%
Before our stories
+1.5% did not move with itCLDX +3.1 · LNTH +1.8 · IDXX +1.3 · NEOG +0.2
3 Oct 22, 2025−8.86%
Before our storiesgroup −0.8%, did not move with it
3Oct 22, 2025−8.86%
Before our stories
−0.8% did not move with itCLDX −4.3 · LNTH −1.0 · IDXX −0.5 · NEOG +4.1
4 Oct 27, 2025−42.23%
Before our storiesgroup +1.7%, did not move with it
4Oct 27, 2025−42.23%
Before our stories
+1.7% did not move with itNEOG +0.3 · IDXX +1.0 · CLDX +2.4 · LNTH +3.7
5 Nov 5, 2025+11.23%
Before our storiesgroup −0.4%, did not move with it
5Nov 5, 2025+11.23%
Before our stories
−0.4% did not move with itNEOG +2.8 · IDXX −0.3 · CLDX −0.5 · LNTH −0.8
6 Nov 6, 2025−9.21%
Before our storiesgroup −2.8%, did not move with it
6Nov 6, 2025−9.21%
Before our stories
−2.8% did not move with itLNTH −6.2 · NEOG −3.7 · CLDX −2.0 · IDXX −0.9
7 Nov 7, 2025−22.73%
Resultsgroup −1.1%, did not move with it
7Nov 7, 2025−22.73%
ResultsFirst close after the Nov 6 results filing
−1.1% did not move with itLNTH −4.9 · CLDX −1.6 · IDXX −0.7 · NEOG +7.0
8 Dec 3, 2025+11.85%
Before our storiesgroup +1.2%, did not move with it
8Dec 3, 2025+11.85%
Before our stories
+1.2% did not move with itCLDX +4.3 · LNTH +2.1 · NEOG +0.3 · IDXX −0.9
9 Jan 12, 2026+10.12%
Before our storiesgroup −1.4%, did not move with it
9Jan 12, 2026+10.12%
Before our stories
−1.4% did not move with itIDXX +1.6 · LNTH −0.1 · NEOG −2.6 · CLDX −6.3
10 Jan 21, 2026+9.35%
Before our storiesgroup +2.8%, did not move with it
10Jan 21, 2026+9.35%
Before our stories
+2.8% did not move with itNEOG +5.6 · CLDX +4.1 · IDXX +1.5 · LNTH +0.8
11 Jan 22, 2026+13.33%
Before our storiesgroup +0.8%, did not move with it
11Jan 22, 2026+13.33%
Before our stories
+0.8% did not move with itCLDX +2.6 · LNTH +1.1 · NEOG +0.6 · IDXX −0.8
12 Feb 5, 2026−10.28%
Before our storiesgroup −0.8%, did not move with it
12Feb 5, 2026−10.28%
Before our stories
−0.8% did not move with itCLDX −7.0 · LNTH −1.6 · IDXX +0.1 · NEOG +0.5
13 Feb 6, 2026+10.73%
Before our storiesgroup +1.1%, did not move with it
13Feb 6, 2026+10.73%
Before our stories
+1.1% did not move with itCLDX +5.2 · NEOG +2.0 · IDXX +0.2 · LNTH +0.1
14 Mar 2, 2026+12.05%
Before our storiesgroup −0.5%, did not move with it
14Mar 2, 2026+12.05%
Before our stories
−0.5% did not move with itLNTH +1.9 · CLDX −0.3 · NEOG −0.7 · IDXX −3.0
15 Mar 3, 2026−11.88%
Before our storiesgroup −1.2%, did not move with it
15Mar 3, 2026−11.88%
Before our stories
−1.2% did not move with itCLDX −3.5 · NEOG −2.2 · IDXX −0.2 · LNTH +3.3
16 Mar 31, 2026+10.04%
Before our storiesgroup +4.0%, did not move with it
16Mar 31, 2026+10.04%
Before our stories
+4.0% did not move with itCLDX +7.6 · NEOG +4.3 · LNTH +3.8 · IDXX +0.9
17 Apr 24, 2026−14.11%
Before our storiesgroup +1.4%, did not move with it
17Apr 24, 2026−14.11%
Before our stories
+1.4% did not move with itCLDX −0.8 · IDXX +0.9 · LNTH +1.8 · NEOG +2.0
18 Jun 4, 2026+13.29%
Before our storiesgroup +1.6%, did not move with it
18Jun 4, 2026+13.29%
Before our stories
+1.6% did not move with itNEOG +3.5 · LNTH +2.6 · IDXX +0.7 · CLDX +0.5
19 Jun 15, 2026+23.20%
Nothing on NTLAgroup +1.9%, did not move with it
19Jun 15, 2026+23.20%
Nothing on NTLANo NTLA story, brief or results filing in our record that day
+1.9% did not move with itCLDX +2.7 · NEOG +2.2 · IDXX +1.6 · LNTH +0.1
20 Jul 16, 2026−9.05%
Nothing on NTLAgroup +2.1%, did not move with it
20Jul 16, 2026−9.05%
Nothing on NTLANo NTLA story, brief or results filing in our record that day
+2.1% did not move with itCLDX −7.6 · LNTH +0.8 · IDXX +3.4 · NEOG +3.5
21 Aug 19, 2026+14.48%
Nothing on NTLAgroup +0.9%, did not move with it
21Aug 19, 2026+14.48%
Nothing on NTLANo NTLA story, brief or results filing in our record that day
+0.9% did not move with itNEOG +5.0 · IDXX +1.6 · LNTH +0.2 · CLDX −0.2

A story on the same day is not a cause, and a group move is not proof either. Group: the median of IDXX, LNTH, NEOG and CLDX that day, the largest companies in NTLA’s SEC industry; “moved with NTLA” means the same direction and at least half the size.

What’s next · results

Before the next report: what the first day after the last four did

Six trading days after each results filing (SEC 8-K, Item 2.02). Day 1 is the first close after each filing: the next day’s for a filing after the close, the same day’s otherwise. 2 of 4 times, day 6 ended on the same side as day 1.

Reported Nov 6, 2025

day 1−22.73%day 6−29.38%

Reported Feb 26, 2026

day 1+6.41%day 6−2.01%

Reported May 11, 2026

day 1+2.34%day 6−9.94%

Reported Aug 6, 2026

day 1+2.46%day 6+7.84%

Next report: expected early NovemberEstimated from the dates of its last four results filings. Not announced. Since the Aug 6 report: +16.23%. Four reports is a small sample.

Every report since 2023 →

Each line is NTLA’s close against its close before the filing, on licensed end-of-day closes. What happened after each report, not a forecast; a move on the day is not a cause.

The numbers · FY2025, filed

SEC EDGAR

Market cap$1.7B

Revenue$67.7M+16.90%

Net income$-412.7M

EPS, diluted$-3.81+27.40%

Operating margin-651.7%

Return on equity-61.5%

All filed figures

Snapshot

SEC EDGAR · FY 2025-12-31

SectorHealthcare

Market Cap$1.7B

Enterprise Value$1.6B

Income$-412.7M

Sales$67.7M

Book/sh$4.79

Cash/sh$1.11

Dividend TTM—

Payout—

Employees—

IPO—

Quick Ratio—

Current Ratio5.08

Debt/Eq—

EPS (ttm)$-3.81

EPS this Y27.4%

EPS past 3/5Y—

Sales past 3/5Y9.1%

EPS Y/Y TTM27.4%

Sales Y/Y TTM16.9%

Shs Outstand140.13M

ROA-49.0%

ROE-61.5%

ROIC-85.5%

Gross Margin—

Oper. Margin-651.7%

Profit Margin-609.9%

Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue by fiscal year

$33.1M

FY21

$52.1M

FY22

$36.3M

FY23

$57.9M

FY24

$67.7M

FY25

Operating leverage — margins

GrossOperatingNet

Financials, annual · income and cash flowSEC EDGAR · open ▸

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it

USD	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$33.1M	$52.1M	$36.3M	$57.9M	$67.7M
Gross Profit	—	—	—	—	—
Operating Income	$-267.9M	$-458.2M	$-515.3M	$-534.3M	$-441.0M
Net Income	$-267.9M	$-474.2M	$-481.2M	$-519.0M	$-412.7M
Diluted EPS	$-3.78	$-6.16	$-5.42	$-5.25	$-3.81
Operating Cash Flow	$-225.0M	$-333.3M	$-394.1M	$-348.9M	$-394.7M
Free Cash Flow	$-237.8M	$-346.8M	$-408.1M	$-354.7M	$-395.9M

Same industry

NTLA against four same-industry peers, a year at 100

NTLA is down 48.0% in a year. Neogen is up 2.2 times, Lantheus Holdings is up 87.1%, Celldex Therapeutics 21.7% and Idexx Laboratories is down 14.5%. All four did more. Weekly closes, Oct 10, 2025 = 100, on a log scale so a 2.2-fold rise and a 48.0% fall both read honestly.

Share this chart

NTLA −48.0%. Neogen ×2.2, Lantheus Holdings +87.1%, Celldex Therapeutics +21.7%, Idexx Laboratories −14.5%. Weekly closes, Oct 10, 2025 = 100, log scale.

Share this chart

End-of-day closes (Databento EOD), the last close of each week. The four peers are the largest US-listed companies by market value in NTLA’s SEC industry (In Vitro & In Vivo Diagnostic Substances) with a year of closes. It shows what the closes did; a move here is not a cause, a forecast or a call.

Same industry

In the screener →

IDXX$40.8B LNTH$6.5B NEOG$2.6B CLDX$2.5B QDEL$739M TKNO$483M MYGN$434M NNNN$242M

Build basket with NTLA Screener

Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.